摘要
目的 为探讨HBeAg 阴性CH- B 患者血清HBV- DNA 定量检测的意义。方法 应用定量PCR法对经肝穿活检确诊的52 例HBeAg 阴性,33 例HBeAg 阳性CH- B 血清进行了HBV- DNA 含量检测,并将HBeAg 阳性与阴性患者HBV- DNA 含量、HBeAg 阴性HBV- DNA 高水平与低水平患者肝脏病理损害分别进行了比较。结果 HBV- DNA 含量HBeAg 阳性患者显著高于阴性患者,HBeAg 阴性HBV- DNA 高水平患者肝脏病理损害明显重于低水平患者( 均P< 005) 。结论 提示血清HBeAg 阳性;确为判断HBV 复制的良好指标; HBeAg 阴性HBV- DNA 高水平者,尤以重视,及时给予抗病毒等治疗实属必要。
Objective: In order to study the significance of detection of HBV-DNA quantity in seum from the negative-HBeAged Patients(NHP) with chronic hepatitis B(CH-B) Methods: HBV-DNA was quantitated in serum from 52 NHP, 33 positive-HBeAged patients (PHP) with CH-B diagnosed by liver biopsy using a quantitive PCR assay. The amount of HBV-DNA of PHP and the liver pathologic lesions of the HBV-DNA high-leveled patients (HLP) in NHP were compared with that of NHP and the HBV-DNA low-leveled patients (LLP), respectively. Results: The results showed that the amount of HBV-DNA of PHP was significantly higher than that of NHP and the liver pathologic lesions of HBV-DNA HLP in NHP was significantly severer than that of LLP. Conclusion: These data indicate HBeAg positiveness is indeed a good marker of HBV duplication and the HBV-DNA HLP in NHP with CH-B should be paid more attention and given the anti-virus therapy.
出处
《泰山医学院学报》
CAS
1999年第3期224-226,共3页
Journal of Taishan Medical College